1. Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. (31st December 2023) Authors: Mastorino, L.; Gelato, F.; Quaglino, P.; Ortoncelli, M.; Ribero, S. Journal: Journal of dermatological treatment Issue: Volume 34:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks. (26th July 2022) Authors: Mastorino, L.; Cantafio Duò, V.L.; Vecco, C.; Gelato, F.; Giordano, S.; Roccuzzo, G.; Cavaliere, G.; Avallone, G.; Ortoncelli, M.; Ribero, S.; Quaglino, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 12(2022) Page Start: e1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗